Skip to main content
Signal8

Malin Life Sciences Holdings Ltd

SEC insider (Form 3/4/5 filer). CIK 0001685138. 10% Owner at Poseida Therapeutics, Inc. (PSTX). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 8, 2025. Located in DUBLIN, IRELAND, L2.

Companies Malin Life Sciences Holdings Ltd has filed insider reports for

  • Poseida Therapeutics, Inc. (PSTX): 10% Owner
Malin Life Sciences Holdings Ltd profile photo

Malin Life Sciences Holdings Ltd

CIK: 0001685138

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Poseida Therapeutics, Inc. logo
PSTX

Poseida Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Poseida Therapeutics, Inc. logo
    PSTX

    Poseida Therapeutics, Inc.

    Jan 8, 2025
    Tender Offer
    Direct
    11.8M shares-

1-1 of 1